BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Business

  Oncorus Pivots to Scale Up Manufacturing with New GMP Facility

  Process development and quality control will begin in 2021, and full manufacturing capabilities at the 88,000-square-foot facility will be available in 2023.

  January 7, 2021

   · 

  2 min read

   · 

  Mark Zipkin
• 

  Could CRISPR Be the Key for Rapidly Aging Children?

  NIH Director Francis Collins and David Liu of the Broad Institute have teamed up to conduct a study utilizing CRISPR, the genome-editing system, to see what they could do in terms of altering the aging process in mice.

  January 7, 2021

   · 

  2 min read

   · 

  Krystle Vermes
• 

  Career Advice

  Top 5 Things to Consider When Evaluating Master’s Programs

  If you are certain that attending graduate school is the right move for you, it’s time to look into the specifics of various programs.

  January 7, 2021

   · 

  4 min read

   · 

  Porschia Parker-Griffin
• 

  Career Advice

  3 Tips for Preparing Graduate School Applications

  Depending on your master’s program of interest and your personal qualifications, you might need to take months (or years) to develop into the type of candidate that is admitted.

  January 7, 2021

   · 

  3 min read

   · 

  Porschia Parker-Griffin
• 

  Obsidian Looks to 2021 Collabs as It Advances its Cell Therapy Platforms

  In the run-up to January’s JP Morgan Healthcare Conference, BioSpace caught up with CEO Paul Wotton to discuss the company’s plans for 2021. More collaborations are key features.

  January 7, 2021

   · 

  4 min read

   · 

  Gail Dutton
• 

  Biopharma Investments Strong in the First Week of 2021

  This week multiple companies have announced millions of investment dollars have flooded their coffers to advance research and development of multiple therapies. BioSpace is rounding up the announcements.

  January 7, 2021

   · 

  5 min read

   · 

  Alex Keown
• 

  Business

  DBV Cuts 200 Jobs to Keep Fighting for Peanut Patch Approval

  DBV announced official restructuring plan for keeping the company afloat.

  January 7, 2021

   · 

  1 min read

   · 

  Kate Goodwin
• 

  Drug Development

  Research Roundup: Blood Test Accurately Predicts Alzheimer’s Disease and More

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

  January 7, 2021

   · 

  5 min read

   · 

  Mark Terry
• 

  Drug Development

  Alnylam Poised for Fourth Drug Approval with Strong Phase III hATTR Results of Vutrisiran

  This morning, Alnylam announced vutrisiran met primary and all secondary endpoints. Here’s everything you need to know about the drug and its purpose.

  January 7, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  COVID-19 Vaccine News: Reactions, Efficacy, Dosing and More

  Although yesterday’s media focus was on the riots at the U.S. Capitol, there was a fair amount of ongoing COVID-19 news. Here’s a look.

  January 7, 2021

   · 

  4 min read

   · 

  Mark Terry